MWZB is pleased to announce the publication of a new book on patent term extension. Patent term extension is a critical factor in protecting the rights of innovator pharmaceutical corporations after expiration of the normal patent term. The text contains sections explaining the applicable law in major markets worldwide where extension is available, including the U.S., EU, Japan, Germany, and more. The chapter on U.S. law was written by MWZB attorneys Brion Heaney and Harry Shubin, who together have nearly 60 years of experience in the prosecution of pharma patents.